LEADER 03703nam  2201165z- 450 
001 9910557363703321
005 20220111
035   $a(CKB)5400000000042255
035   $a(oapen)https://directory.doabooks.org/handle/20.500.12854/77121
035   $a(oapen)doab77121
035   $a(EXLCZ)995400000000042255
100   $a20202201d2021      |y         0
101 0 $aeng
135   $aurmn|---annan
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aNovel Treatment Strategies for Glioblastoma
210   $aBasel, Switzerland$cMDPI - Multidisciplinary Digital Publishing Institute$d2021
215   $a1 online resource (268 p.)
311 08$a3-0365-2599-8 
311 08$a3-0365-2598-X 
330   $aThis book is a compilation of articles that brings together current knowledge from an international team of contributors who are dedicated investigators exploring novel strategies for the treatment of glioblastoma. These articles describe some of the latest concepts that will provide students, researchers and clinicians with an overview of the therapeutic approaches being developed in the field of neuro-oncology to combat this deadly disease.
606   $aMedicine$2bicssc
610   $aangiopoietin (Ang)
610   $aanti-angiogenesis
610   $aanticancer
610   $abrain cancer
610   $abrain tumor
610   $acancer stem cell
610   $acancer stem cell niche
610   $acancer stem cells
610   $acell cycle
610   $achimeric antigen receptor (CAR) T cells
610   $aCK2
610   $aCRISPR/Cas9
610   $aCX-4945
610   $ade novo purine synthesis
610   $adifferentiation
610   $adrug repurposing
610   $adrug targets
610   $adrug-inducible gene expression
610   $aendothelial nitric oxide synthase (eNOS)
610   $aGBM
610   $agene therapy
610   $aglioblastoma
610   $aglioblastoma (GB)
610   $aglioblastoma multiforme
610   $aglioma
610   $aimmune checkpoint inhibitors
610   $aimmunotherapy
610   $ainvadopodia
610   $ainvasion
610   $aion channels
610   $aMardepodect
610   $ametabolic reprogramming
610   $ametabolic treatment
610   $amigration
610   $an/a
610   $ananomedicine
610   $anerve/glial antigen 2
610   $anew trial design
610   $anewly diagnosed glioblastoma
610   $aNG2
610   $anovel therapy
610   $aone-carbon metabolism
610   $aorganoids
610   $aP-bi-TAT
610   $aP-m-TAT
610   $aPEG
610   $apersonalized treatment
610   $apluripotent stem cells
610   $aproliferation
610   $aprolyl-oligopeptidase (POP)
610   $aradiotherapy
610   $aRAS
610   $arecurrent glioblastoma
610   $aRegorafenib
610   $arenin-angiotensin system
610   $aSRGAP2
610   $astem cell
610   $atargeted therapy
610   $atemozolomide
610   $atetrac
610   $athyrointegrin ?v?3
610   $aTP53
610   $atransforming growth factor-? (TGF-?)
610   $atriazole tetrac
610   $atumor antigens
610   $atumor microenvironment
610   $avaccine
610   $avascular endothelial growth factor (VEGF)
610   $aviral vectors
615  7$aMedicine
700   $aStylli$b Stanley$4edt$01314841
702   $aStylli$b Stanley$4oth
906   $aBOOK
912   $a9910557363703321
996   $aNovel Treatment Strategies for Glioblastoma$93032034
997   $aUNINA